|
2025
|
Invention
|
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases.
Provided h... |
|
2024
|
Invention
|
Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease.
Pro... |
|
2023
|
Invention
|
Anti-flt-1 antibodies for treating duchenne muscular dystrophy. The present invention provides, a... |
|
2022
|
Invention
|
Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease. Prov... |
|
|
Invention
|
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases. Provided he... |
|
|
Invention
|
Imidazopyridinyl inhibitors of plasma kallikrein. The present invention provides compounds and co... |
|
|
Invention
|
Plasma kallikrein inhibitors. The present invention provides compounds and compositions thereof w... |
|
|
Invention
|
Heteroaryl inhibitors of plasma kallikrein. The present invention provides compounds and composit... |
|
|
Invention
|
Inhibitors of plasma kallikrein. The present invention provides compounds and compositions thereo... |
|
|
Invention
|
Polycyclic inhibitors of plasma kallikrein. The present invention provides compounds and composit... |
|
2021
|
Invention
|
Forms and compositions of inhibitors of plasma kallikrein. The present invention provides solid f... |
|
|
Invention
|
Solid forms of inhibitors of plasma kallikrein. The present invention provides compounds and comp... |
|
|
Invention
|
Needle connectors and modular needle connectors for multi-dose drug delivery devices and methods ... |
|
2020
|
Invention
|
Adeno associated virus vectors for the treatment of hunter disease. The present disclosure provid... |
|
|
Invention
|
Methods for detecting oligonucleotides. The present disclosure describes methods for detecting ol... |
|
|
Invention
|
Systems and methods for electronic portfolio management. Described herein are embodiments of an e... |
|
|
Invention
|
Adeno-associated virus vectors based gene therapy for hereditary angioedema. The present disclosu... |
|
|
Invention
|
Heteroaryl plasma kallikrein inhibitors. The present invention provides compounds and composition... |
|
|
Invention
|
Plasma kallikrein inhibitors and uses thereof. The present invention provides compounds and compo... |
|
|
Invention
|
Recombinant heme oxygenase-1 (ho-1) for the treatment of sickle cell disease. The present inventi... |
|
|
Invention
|
Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dys... |
|
|
Invention
|
Adeno associated viral vector delivery of antibodies for the treatment of disease mediated dysreg... |
|
|
Invention
|
Isofagomine salts, methods of use and formulations. The present invention relates generally to th... |
|
|
P/S
|
Pharmaceutical assistance programs providing patients, patient caregivers and healthcare professi... |
|
|
Invention
|
Htt repressors and uses thereof. Disclosed herein are HTT repressors and methods and compositions... |
|
2019
|
Invention
|
Purification of iduronate-2-sulfatase immunoglobulin fusion protein. The present invention relate... |
|
|
Invention
|
Anti-flt-1 antibodies in treating bronchopulmonary dysplasia. The present invention provides, amo... |
|
|
Invention
|
Methods and compositions for treatment of hunter syndrome.
The present invention provides, among... |
|
|
Invention
|
Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof. The present inv... |
|
|
Invention
|
Affinity purification of glycoside-cleaving enzymes. e.ge.g., a-galactosidase A (α-Gal A), glucoc... |
|
|
Invention
|
Syringe screening device. The present disclosure is directed to a device for screening pre-filled... |
|
|
Invention
|
Amphetamine-guanfacine combinations for treatment of neuropsychiatric disorders. The invention re... |
|
2018
|
Invention
|
Purified arylsulfatase a and compositons thereof. The present invention provides, among other thi... |
|
|
Invention
|
Devices and methods for detecting dosage administration. Systems and methods for detecting admini... |
|
|
Invention
|
Formulations comprising glucocerebrosidase and isofagomine. The invention provides a composition ... |
|
|
Invention
|
Methods and compositions for treating chronic lung diseases. The present invention provides metho... |
|
|
Invention
|
Antibody-resin coupling apparatus and methods. An antibody-resin coupling apparatus quickly and e... |
|
|
P/S
|
Questionnaires on health for use by medical professionals to assess the needs of premature infants |
|
|
Invention
|
Recombinant follistatin-fc fusion proteins and use in treating duchenne muscular dystrophy. The p... |
|
|
Invention
|
Anti-flt-1 antibodies in treating duchenne muscular dystrophy.
The present invention provides, a... |
|
|
Invention
|
Compounds and compositions for the treatment of ophthalmic disorders. Described herein are method... |
|
|
Invention
|
A physiological sensing and therapeutic administration system and method. Embodiments of the pres... |
|
|
Invention
|
A drug monitoring tool. Embodiments of the present disclosure relate to a drug monitoring tool. T... |
|
|
Invention
|
Smart tourniquet. A smart tourniquet for self-administering a medication is provided. When a pati... |
|
2017
|
P/S
|
Providing referrals in the field of health care. Charitable services, namely, providing financial... |
|
|
Invention
|
Anti-ccl2 antibodies for treatment of scleroderma.
The present invention provides, among other t... |
|
|
P/S
|
Health care services; providing information about health care. |
|
|
Invention
|
Anti-c5 antibodies with enhanced ph switch.
Multi-specific molecules (e.g., engineered antibodie... |
|
2016
|
P/S
|
Pharmaceutical preparations for the treatment of lysosomal storage disease caused by enzyme defic... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations... |
|
2015
|
P/S
|
Guarantee services in the nature of preparation and dispensing of medications, namely, providing ... |
|
|
P/S
|
Training services in the field of self-administration of medications; training services in the fi... |
|
2014
|
P/S
|
Downloadable software for use in the field of health care, namely, software for tracking changes ... |
|
2013
|
P/S
|
Health care services; health care services relating to enzyme deficiencies and lysosomal storage ... |
|
2011
|
P/S
|
Pharmaceutical preparations for use in connection with humans and animals, all the aforementioned... |
|
2010
|
P/S
|
[ Downloadable software for use in the field of health care, namely, software for tracking change... |
|
|
P/S
|
Downloadable software in the nature of a mobile application for use by Gaucher's disease patients... |
|
2009
|
P/S
|
Pharmaceutical preparations for the treatment of enzyme
deficiencies; pharmaceutical preparation... |
|
2007
|
P/S
|
Pharmaceutical preparations for the treatment of Hunter's syndrome. Providing medical and scienti... |
|
|
P/S
|
Pharmaceutical preparations for treating enzyme deficiencies. Providing medical and scientific re... |
|
|
P/S
|
Pharmaceutical preparations for treating enzyme deficiencies. Providing scientific research infor... |
|
2006
|
P/S
|
Pharmaceutical preparations for the treatment of enzyme deficiencies; Pharmaceutical preparations... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of enzyme deficiencies; pharmaceutical prepa... |
|
|
P/S
|
Providing health and medical information to Hunter's syndrome patients, their families and their ... |
|
2005
|
P/S
|
Pharmaceutical preparations for use in the treatment of Fabry's disease. |
|
2003
|
P/S
|
Pharmaceuticals for use in the treatment of enzyme deficiency diseases |
|
2000
|
P/S
|
Pharmaceutical preparations for use in the treatment of Fabry's disease. |
|
|
P/S
|
Printed booklets, pamphlets and brochures containing information about pharmaceuticals, diseases,... |
